BL
ELV icon

Balentine LLC’s Elevance Health ELV Stock Holding History

Balentine LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Buy
1,114
+3
+0.3% +$986 0.01% 148
2025
Q4 		$389K Buy
+1,111
New +$375K 0.01% 141
2025
Q3 		– Sell
-542
Closed -$211K – 238
2025
Q2 		$211K Hold
542
– – 0.01% 158
2025
Q1 		$236K Sell
542
-35
-6% -$14.1K 0.01% 146
2024
Q4 		$213K Sell
577
-1,506
-72% -$630K 0.01% 135
2024
Q3 		$1.08M Buy
2,083
+1,506
+261% +$805K 0.04% 63
2024
Q2 		$313K Sell
577
-1,328
-70% -$702K 0.01% 98
2024
Q1 		$988K Sell
1,905
-43
-2% -$21.4K 0.03% 192
2023
Q4 		$918K Sell
1,948
-386
-17% -$178K 0.03% 183
2023
Q3 		$1.02M Buy
2,334
+158
+7% +$71.7K 0.03% 146
2023
Q2 		$967K Sell
2,176
-436
-17% -$201K 0.03% 159
2023
Q1 		$1.2M Sell
2,612
-1,176
-31% -$560K 0.04% 142
2022
Q4 		$1.94M Sell
3,788
-254
-6% -$129K 0.07% 106
2022
Q3 		$1.84M Sell
4,042
-5,097
-56% -$2.44M 0.07% 86
2022
Q2 		$4.41M Buy
9,139
+4,696
+106% +$2.32M 0.16% 46
2022
Q1 		$2.18M Buy
4,443
+3,058
+221% +$1.4M 0.07% 78
2021
Q4 		$642K Buy
1,385
+327
+31% +$138K 0.02% 138
2021
Q3 		$395K Buy
1,058
+495
+88% +$188K 0.02% 149
2021
Q2 		$215K Buy
+563
New +$215K 0.01% 160
2020
Q3 		– Sell
-122
Closed -$32K – 365
2020
Q2 		$32K Sell
122
-450
-79% -$120K ﹤0.01% 302
2020
Q1 		$130K Buy
572
+347
+154% +$94.6K 0.01% 105
2019
Q4 		$68K Buy
225
+173
+333% +$47.6K ﹤0.01% 151
2019
Q3 		$12K Buy
52
+20
+63% +$5.48K ﹤0.01% 310
2019
Q2 		$9K Buy
+32
New +$8.74K ﹤0.01% 327
2015
Q3 		– Sell
-268
Closed -$44K – 460
2015
Q2 		$44K Hold
268
– – 0.01% 159
2015
Q1 		$41K Buy
+268
New +$38.2K 0.01% 166

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Balentine LLC's ELV Position: Q1 2026 in Review

Balentine LLC increased its Elevance Health (ELV) stake by 0.27% in Q1 2026, buying an estimated $986 and bringing the position to 1,114 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #148.

Balentine LLC first reported a position in ELV in Q1 2015 and has held it in 26 quarters since. The position peaked at $4.41M in Q2 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Balentine LLC held 1,114 shares of Elevance Health worth $326K as of Q1 2026.
  • Balentine LLC bought 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up 0.01% of Balentine LLC's portfolio in Q1 2026, its #148 holding.
  • Balentine LLC first reported a position in Elevance Health in Q1 2015 and has held it in 26 quarters since.
  • Balentine LLC's Elevance Health position peaked at $4.41M in Q2 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.